The burgeoning field ofstudies" into novel anxiolytics is rapidly expanding, with untapped research chemicals showing favorable results in preclinical and clinical experiments. These substances often exhibit distinct mechanisms of action compared to traditional anti-anxiety medications, offering potential improvements for subjects struggling with a